From Mice to Men. Commonalities in Physiology for Stem Cell-Based Cardiac Repair

Journal of the American College of Cardiology

Volumn 54, Issue 24, 2009, Pages 2287-2289

  Penn, Marc S ^a   Anwaruddin, Saif ^a   Nair, Ravi ^a   Ellis, Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

allogeneic; echocardiography; magnetic resonance imaging; mesenchymal stem cells; myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; CELL TYPE; EDITORIAL; HEART ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STEM CELL TRANSPLANTATION;

HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION;

EID: 70549103271     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.054     Document Type: Editorial

References (19)

1. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
2. Leri A., Kajstura J., Anversa P., and Frishman W.H. Myocardial regeneration and stem cell repair. Curr Probl Cardiol 33 (2008) 91-153
3. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54 (2009) 2277-2286
4. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
5. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
6. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
7. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
8. Penn M.S. Stem-cell therapy after acute myocardial infarction: the focus should be on those at risk. Lancet 367 (2006) 87-88
9. Penn M.S., and Mangi A.A. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res 102 (2008) 1471-1482
10. Penn M.S., Zhang M., Deglurkar I., and Topol E.J. Role of stem cell homing in myocardial regeneration. Int J Cardiol 95 Suppl 1 (2004) S23-S25
11. Tang Y.L., Zhu W., Cheng M., et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor-cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104 (2009) 1209-1216
12. Askari A., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet 362 (2003) 697-703
13. Schenk S., Mal N., Finan A., et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25 (2007) 245-251
14. Zhang M., Mal N., Kiedrowski M., et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes following myocardial infarction. FASEB J 21 (2007) 3197-3207
15. Zhang Z., Deb A., Zhang Z., et al. Secreted frizzled related protein 2 protects cells from apoptosis by blocking the effect of canonical Wnt3a. J Mol Cell Cardiol 46 (2009) 370-377
16. Deglurkar I., Mal N., Mills W.R., et al. Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther 17 (2006) 1144-1151
17. Burchfield J.S., Iwasaki M., Koyanagi M., et al. Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction. Circ Res 103 (2008) 203-211
18. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
19. Mills W.R., Mal N., Kiedrowski M.J., et al. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 42 (2007) 304-314